Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

Surgical Treatment of Cavus Foot in Charcot-Marie-Tooth Disease: A Review of Twenty-four Cases: AAOS Exhibit Selection.

Faldini C, Traina F, Nanni M, Mazzotti A, Calamelli C, Fabbri D, Pungetti C, Giannini S.

J Bone Joint Surg Am. 2015 Mar 18;97(6):e30. doi: 10.2106/JBJS.N.00794.

PMID:
25788311
2.

Surgical treatment of aseptic forearm nonunion with plate and opposite bone graft strut. Autograft or allograft?

Faldini C, Traina F, Perna F, Borghi R, Nanni M, Chehrassan M.

Int Orthop. 2015 Mar 18. [Epub ahead of print]

PMID:
25776465
3.

Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea.

Lopes FC, Traina F, Almeida CB, Leonardo FC, Franco-Penteado CF, Garrido VT, Colella MP, Soares R, Olalla-Saad ST, Costa FF, Conran N.

Haematologica. 2015 Mar 13. pii: haematol.2014.119727. [Epub ahead of print]

PMID:
25769545
Free Article
4.

Current concepts in the biopsy of musculoskeletal tumors.

Traina F, Errani C, Toscano A, Pungetti C, Fabbri D, Mazzotti A, Donati D, Faldini C.

J Bone Joint Surg Am. 2015 Jan 7;97(1):e7.

PMID:
25723000
5.

Preservation of hamstring tibial insertion in anterior cruciate ligament reconstruction: a review of the current literature.

Ruffilli A, Traina F, Evangelisti G, Borghi R, Perna F, Faldini C.

Musculoskelet Surg. 2015 Feb 8. [Epub ahead of print]

PMID:
25663060
6.

Current concepts in the biopsy of musculoskeletal tumors: AAOS exhibit selection.

Traina F, Errani C, Toscano A, Pungetti C, Fabbri D, Mazzotti A, Donati D, Faldini C.

J Bone Joint Surg Am. 2015 Jan 21;97(2):e7. doi: 10.2106/JBJS.N.00661. Review.

PMID:
25609446
7.

Elevated hypercoagulability markers in hemoglobin SC disease.

Colella MP, de Paula EV, Machado-Neto JA, Conran N, Annicchino-Bizzacchi JM, Costa FF, Olalla Saad ST, Traina F.

Haematologica. 2015 Jan 16. pii: haematol.2014.114587. [Epub ahead of print]

8.

ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells.

Machado-Neto JA, Lazarini M, Favaro P, de Melo Campos P, Scopim-Ribeiro R, Franchi GC Junior, Nowill AE, Lima PR, Costa FF, Benichou S, Olalla Saad ST, Traina F.

Biochim Biophys Acta. 2015 Mar;1853(3):583-593. doi: 10.1016/j.bbamcr.2014.12.012. Epub 2014 Dec 16.

PMID:
25523139
9.

Minimally invasive technique for curettage of chondroblastoma using endoscopic technique.

Errani C, Traina F, Chehrassan M, Donati D, Faldini C.

Eur Rev Med Pharmacol Sci. 2014 Nov;18(22):3394-8.

10.

Myelodysplastic syndrome with synchronous gastric cancer: when the symptoms suggest something else.

de Melo Campos P, Traina F, Lorand-Metze I, Olalla Saad ST.

Rev Bras Hematol Hemoter. 2014 Nov-Dec;36(6):442-4. doi: 10.1016/j.bjhh.2014.07.005. Epub 2014 Jul 17.

11.

Imatinib restores VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells.

Bernusso VA, Machado-Neto JA, Pericole FV, Vieira KP, Duarte AS, Traina F, Hansen MD, Olalla Saad ST, Barcellos KS.

Biochim Biophys Acta. 2015 Feb;1853(2):388-95. doi: 10.1016/j.bbamcr.2014.11.008. Epub 2014 Nov 15.

PMID:
25450971
12.

Ten-Eleven-Translocation 2 (TET2) is downregulated in myelodysplastic syndromes.

Scopim-Ribeiro R, Machado-Neto JA, Campos PD, Silva CA, Favaro P, Lorand-Metze I, Costa FF, Saad ST, Traina F.

Eur J Haematol. 2014 Sep 8. doi: 10.1111/ejh.12445. [Epub ahead of print]

PMID:
25200248
13.

Pyrimidine-5'-nucleotidase Campinas, a new mutation (p.R56G) in the NT5C3 gene associated with pyrimidine-5'-nucleotidase type I deficiency and influence of Gilbert's Syndrome on clinical expression.

Santos Ad, Dantas LE, Traina F, Albuquerque DM, Chaim EA, Saad ST.

Blood Cells Mol Dis. 2014 Dec;53(4):246-52. doi: 10.1016/j.bcmd.2014.05.009. Epub 2014 Aug 18.

PMID:
25153905
14.

Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412.

de Melo Campos P, Machado-Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte AS, Barra FF, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Olalla Saad ST, Traina F.

Leuk Res. 2014 Oct;38(10):1245-51. doi: 10.1016/j.leukres.2014.07.010. Epub 2014 Aug 1.

PMID:
25139846
15.

Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.

Guelsin GA, Rodrigues C, Visentainer JE, De Melo Campos P, Traina F, Gilli SC, Saad ST, Castilho L.

Blood Transfus. 2015 Jan;13(1):53-8. doi: 10.2450/2014.0332-13. Epub 2014 Jun 12.

16.

ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells.

Machado-Neto JA, Lazarini M, Favaro P, Franchi GC Jr, Nowill AE, Saad ST, Traina F.

Exp Cell Res. 2014 Jun 10;324(2):137-45. doi: 10.1016/j.yexcr.2014.04.004. Epub 2014 Apr 12.

PMID:
24726915
17.

Post-operative limb position can influence blood loss and range of motion after total knee arthroplasty: a systematic review.

Faldini C, Traina F, De Fine M, Pedrini M, Sambri A.

Knee Surg Sports Traumatol Arthrosc. 2015 Mar;23(3):852-9. doi: 10.1007/s00167-013-2732-4. Epub 2013 Oct 25.

PMID:
24682489
18.

Stathmin 1 in normal and malignant hematopoiesis.

Machado-Neto JA, Saad ST, Traina F.

BMB Rep. 2014 Dec;47(12):660-5.

19.

YAP1 expression in myelodysplastic syndromes and acute leukemias.

Machado-Neto JA, de Melo Campos P, Olalla Saad ST, Traina F.

Leuk Lymphoma. 2014 Oct;55(10):2413-5. doi: 10.3109/10428194.2014.891028. Epub 2014 Mar 10. No abstract available.

PMID:
24605912
20.

Endothelial activation by platelets from sickle cell anemia patients.

Proença-Ferreira R, Brugnerotto AF, Garrido VT, Dominical VM, Vital DM, Ribeiro Mde F, dos Santos ME, Traina F, Olalla-Saad ST, Costa FF, Conran N.

PLoS One. 2014 Feb 13;9(2):e89012. doi: 10.1371/journal.pone.0089012. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk